In our November issue of Pharmaceutical Executive
FEATURES
Cover Feature
Pharm Exec’s 2020 Pipeline Report
Joseph Constance
Our Annual Pipeline Report examines six key areas of biopharma R&D—a mix of emerging and maturing—where, for some, promising research efforts are now beginning to pay dividends, as novel advances in science usher in new treatment approaches and curative therapies.
Download the digital issue
|
ADVERTISEMENT
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
 Register Now |
Interview
R. Jude Samulski: Gene Therapy’s Guiding Force
Elaine Quilici
Pharm Exec chronicles the journey of gene therapy visionary R. Jude Samulski, whose work unraveling the mysteries of adeno-associated virus continues to fuel new hopes in transforming drugs for rare disease.
Download the digital issue |
ADVERTISEMENT
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 15, 2019 at 5pm JST
Tuesday, October 29, 2019 at 11am JST
 Register Now |
Technology
Closing the Science and Manufacturing Divide
Lisa Henderson
With pursuits of complex therapies more routine, biotech platform companies are tasked with aligning their science with process and manufacturing proficiency to stand out in an increasingly crowded investment field.
Download the digital issue |
ADVERTISEMENT
Launch Strategies: Trends and Challenges for Biotech Companies
Wednesday, October 23, 2019 at 10am EDT
 Register Now |
Technology
Biosensors in Pharma: A Dose of Optimism
Julian Upton
A look at the biosensor technology grabbing the attention of watchful industry.
Download the digital issue |
ADVERTISEMENT
Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk
Wednesday, November 20, 2019 at 10am EST| 9am CST| 3pm GMT| 4pm CET
 Register Now |
ALSO IN THIS ISSUE
The Pace of Massive Innovation
Lisa Henderson
Though uncertain market dynamics remain at play, the current magnitude of innovation in biopharma is staggering, and, at times, overwhelming …Read more
Debate Heats Up Over Reference Pricing Plan
Jill Wechsler
Measure would cut drug costs, slash revenues, curb R&D …Read more
The Quest to Measure Drug Effectiveness
Reflector
A formal effort is underway in Europe to gather concrete clues on the value of real-world evidence in payer decision-making…Read more
|
ADVERTISEMENT
A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
November 13, 2019 at 2pm EDT | 1pm CDT | 11am PDT
 Register Now |
